Waddell & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Sell
1,765
-223
-11% -$41K 0.02% 377
2026
Q1
$375K Sell
1,988
-471
-19% -$99.2K 0.02% 291
2025
Q4
$489K Buy
2,459
+946
+63% +$191K 0.03% 180
2025
Q3
$307K Buy
+1,513
New +$268K 0.03% 209

Other funds holding THC

Waddell & Associates's THC Position: Q2 2026 in Review

Waddell & Associates reduced its Tenet Healthcare (THC) stake by 11% in Q2 2026, selling an estimated $41K and leaving 1,765 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #377.

Waddell & Associates first reported a position in THC in Q3 2025 and has held it in 4 quarters since. The position peaked at $489K in Q4 2025. 176 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Waddell & Associates held 1,765 shares of Tenet Healthcare worth $330K as of Q2 2026.
  • Waddell & Associates sold 223 Tenet Healthcare shares in Q2 2026, an estimated $41K.
  • Tenet Healthcare made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #377 holding.
  • Waddell & Associates first reported a position in Tenet Healthcare in Q3 2025 and has held it in 4 quarters since.
  • Waddell & Associates's Tenet Healthcare position peaked at $489K in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.